Navigation Links
Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids
Date:3/10/2008

people attempt to incorporate into their diets? According to Dr. O'Keefe, people with known coronary artery disease should consume about 1 gram per day, while people without disease should consume at least 500 milligrams (mg) per day.

"Patients with high triglyceride levels can benefit from treatment with 3 to 4 grams daily of DHA and EPA," says Dr. O'Keefe. "Research shows that this dosage lowers triglyceride levels by 20 to 50 percent."

About two meals of oily fish can provide 400 to 500 mg of DHA and EPA, so patients who need to consume higher levels of these fatty-acids may choose to use fish oil supplements to reach these targets.

Dr. O'Keefe also notes that research supports the effectiveness of combining the consumption of fish oil with the use of cholesterol-lowering medications called statins. Combination therapy with omega-3 fatty acids and a statin is a safe and effective way to improve lipid levels and cardiovascular health beyond the benefits provided by statin therapy alone. Blood DHA and EPA levels could one day be used to identify patients with deficient levels and to individualize therapeutic recommendations.

Dr. O'Keefe found little evidence of serious adverse effects associated with fish oil consumption. "In prospective placebo-controlled trials, no adverse effects were observed to occur at a frequency of more than 5 percent, and no difference in frequency was noted between the placebo and omega-3 fatty acid groups," he says.

The most commonly observed side effects include nausea, upset stomach and a "fishy burp." Taking the supplement at bedtime or with meals, keeping fish oil capsules in the freezer or using enteric-coated supplements may help reduce burping and upset stomach symptoms.

A peer-review journal, Mayo Clinic Proceedings publishes original articles, reviews and editorials dealing with clinical and laboratory medicine, clinical research, basic science research and clinical epidemio
'/>"/>

SOURCE Mayo Clinic Proceedings
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
2. New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care
3. Ception Therapeutics Initiates Phase II/III Clinical Trial for Its Lead Product Reslizumab in Eosinophilic Esophagitis (EE) in Children
4. New Clinical Data Further Supports Chromium Picolinates Role in Enhancing Brain Activity in Older Adults
5. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
6. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
7. EDICT Opens Public Comment Period for Clinical Trials Policy Recommendations
8. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
9. Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone)
10. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
11. Mayo Clinic Finds Capsule Endoscopy Can Detect Intestinal Damage Caused by Celiac Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...a/--ChindexInternational,Inc.,("Chindex")(Nasdaq: ...n,healthcareproductsandservicesinthePeople,sRepubl...he21stAnnualPiperJaffray,"Unplugged"HealthCareConf...eHotel. , Managementiscurrentlyscheduledtopre...e-on-onemeetingsthroughouttheday.Awebcast,ofthepre...
(Date:11/24/2009)...ll/--AnadysPharmaceuticals,Inc.(Nasdaq: ANDS )anno...frayHealthcareConferenceonTuesday,December1,2009at...tTheNewYorkPalaceHotel.SteveWorland,Ph.D.,Presiden...rviewofAnadysanditsclinicaldevelopmentprograms,ANA...simultaneouslywebcastandcanbeaccessedontheInvestor...
(Date:11/24/2009)...-ZargisMedicalCorp.,asubsidiaryofSpeedusCorp.(Nasd...(NYSE: SI ),todayannouncedthatitsZargisCardioscand...TheEarlyShow duringasegmentinwhichMarkJannot,theed...productsfromthepublication,s2009"BestofWhat,sNew"a...ionmorningnewstalkshowbroadcastbyCBSfromNewYorkCit...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3Cystic Fibrosis Treatment May Cause Hearing Loss 50673 1Cardinal Health Appoints Bruce Downey to Board of Directors 3B John McCoy Retires From Board After 22 Years 50670 1Cardinal Health Appoints Bruce Downey to Board of Directors 3B John McCoy Retires From Board After 22 Years 50670 2CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 1CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 2CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 3
...mmary: Proprietary DNA delivery technology enables...cells - reduces,atherosclerosis progression in mou...WIRE)--Mar 26, 2007 - Research conducted,at Clevel...lege of,Cardiology,s 58th Annual Scientific Sessio...ing the anti-inflammatory protein,interferon-beta ...
...ISIS 301012 coadministered with statins for only f...the levels achieved with,statins alone, with simil..., NEW ORLEANS and CARLSBAD, Calif., March 26, 2007...nc. announced new,results from its Phase 2 clinica... presented today at the of Cardiology,Annual Scien...
Other Medicine Technology:Interferon Beta DNA Treatment Delivered with Ichor Technology,Reduces Atherosclerosis Progression in Mice 2Interferon Beta DNA Treatment Delivered with Ichor Technology,Reduces Atherosclerosis Progression in Mice 3Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 2Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 3Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 4Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 5Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 6Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 7Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 8Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 9
(Date:11/25/2009)...swire-USNewswire/--TheAmericanAssociationforHomeca...S.2128,whichisdesignedtosubstantiallyimprovetoolsa...llwasintroducedbySen.GeorgeLeMieux(R-Fla.). ,, ...AssociationforHomecareoutlinedinits13-pointanti-fr...sinFebruary.Thoseprovisionsincludecallingforreal-t...
(Date:11/25/2009)...at can occur in children with autism and related c...t includes medication combined with a structured t...versity researchers and their colleagues. , Pub...of the American Academy of Child and Adolescent Ps... Institute of Mental Health (NIMH) Research Units ...
(Date:11/25/2009)...ve expands to include cost-effective, sustainable ...thcare professionals in developing world. , ... 25, 2009 -- Elluminate, Inc. , the leader in we...hat support 21st century teaching, learning, and c...ce initiative was awarded iNACOL,s first-ever Ou...
(Date:11/25/2009)...Newswire/--TwomoreH1N1vaccineclinicshavebeenschedu...ntyHealthDepartmentannouncedtoday.Theyarebeingoffe...rkinSterlingHeights. ,, TheDec.3clinicwillbehel....Thethimerosol-freeversionoftheinjectablevaccinewi...ectableandnasalsprayimmunizationwillbeoffered.Preg...
(Date:11/25/2009)...gresstoImproveOverallOutcomesforLungCancer ,,...,LungCancerAlliance-California(LCA-CA)issuedits2nd...anassessmentofprogressbeingmadeagainstthislethaldi...CancerAlliance(LCA),theonlynationalorganizationded...plelivingwithoratriskforlungcancer. ,, (Photo: ...
Breaking Medicine News(10 mins):Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5Health News:Macomb County Health Department Schedules Two More H1N1 Flu Vaccine Clinics Dec. 3 and 5 2Health News:Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer 2
...ld Allow Condom Distribution in CA Correctional,Fa...lifornia HIV Advocacy Coalition (SCHAC) and the Ca... on Tuesday, October 2, at 10:00 a.m. (in front,of...y Act" (Swanson, D, Oakland), which will help redu...
...stored normal blood pressure, study finds , ...n study has identified overweight as a direct caus...up to half of overweight people can bring down blo... Dr. Roberto Fogari, professor of medicine at the ...
...to warn Americans about risks of indoor tanning de...rtant step,which may help reduce significantly the...Bush yesterday signed the Tanning Accountability a... directs the U.S. Food and Drug Administration (FD...
...as An inflammatory eye condition that is one of t...ated much more effectively and easily thanks to a ...ory rats, scientists at the University of Texas Me... outer surface of the eyeball and includes the iri...
... be Cut; Plan Changes Will Reduce Cost Increases b... HARRISBURG, Pa., Sept. 28 The Office of,Administ... Retired,Employees Health Program (REHP) that will...challenges facing,employers across the country," S...
...2007 (Aliso Viejo, CA) Ossur, a trusted and globa...etic innovations than any other company in the fie...s the winner of a 2007 da Vinci Award. , The PR...lectronics, mechanics, and human physiology that r...
Other Medicine News:Health News:Community Leaders to Host Press Event at L.A. Central Jail Urging Governor to Sign AB 1334 2Health News:Weight Loss Can Control Hypertension 2Health News:Weight Loss Can Control Hypertension 3Health News:American Academy of Dermatology Association Commends President Bush for Signing Tanning Accountability and Notification (TAN) Act 2Health News:New discovery may improve treatment of one of the world's leading causes of blindness 2Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 2Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 3Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 4Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 5Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 6Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 7Health News:Ossur's Proprio Foot nets the 2007 da Vinci Award 2
Full Handle Laseredge Implant Blade Knife, 3.2 mm round tip
Full Handle Laseredge Implant Blade Knife, 5.2 mm angled bevel up
Full Handle Laseredge Implant Blade Knife, 4.0 mm angled bevel up
Full Handle Laseredge Crescent Blade Knife, angled bevel down
Medicine Products: